Mark A. Lumley
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Mark A. Lumley sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Mark A. Lumley: 4 sponsored US clinical trials, 1 recruiting.
Mark A. Lumley sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Chronic Musculoskeletal Pain, with 1 trials.
Upper-quartile sponsor footprint
Mark A. Lumley sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Comparing Single-Session Therapies for Chronic Pain
NCT07008105
Experiential Training in Eliciting Disclosure & Emotions for Mental Health Trainees
NCT04511754
The Pain & Stress Interview Study for People With Chronic Pain
NCT04498663
Family Meeting Study for End Stage Renal Disease
NCT02504021
Therapeutic Areas
What is open in the Mark A. Lumley pipeline
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Chronic Musculoskeletal Pain (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Mark A. Lumley: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Mark A. Lumley sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Mark A. Lumley page
4 registered trials is a research-attention snapshot, not an endorsement of Mark A. Lumley or any single study.
- 1 of Mark A. Lumley's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Musculoskeletal Pain is the condition Mark A. Lumley studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Musculoskeletal Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mark A. Lumley pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.